G. Vandermoten
- Topics
- Lung Cancer Research Studies (14 papers)Neuroendocrine Tumor Research Advances (9 papers)Cancer therapeutics and mechanisms (6 papers)
- Partner nations
- BelgiumUnited States
In The Last Decade
G. Vandermoten
19 papers receiving 703 citations
Peers
Comparison fields: 5 of 77
- Oncology 524
- Pulmonary and Respiratory Medicine 470
- Molecular Biology 210
- Epidemiology 162
- Surgery 64
Countries citing papers authored by G. Vandermoten
This map shows the geographic impact of G. Vandermoten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Vandermoten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Vandermoten more than expected).
Fields of papers citing papers by G. Vandermoten
This network shows the impact of papers produced by G. Vandermoten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Vandermoten. The network helps show where G. Vandermoten may publish in the future.
Co-authorship network of co-authors of G. Vandermoten
This figure shows the co-authorship network connecting the top 25 collaborators of G. Vandermoten. A scholar is included among the top collaborators of G. Vandermoten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Vandermoten. G. Vandermoten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 19 | |
| 3 | 61 | |
| 4 | 25 | |
| 5 | 198 | |
| 6 | 18 | |
| 7 | A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party. | 3 |
| 8 | 113 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | Bronchial obstruction caused by a solitary endobronchial non-Hodgkin lymphoma. | 3 |
| 12 | 12 | |
| 13 | 13 | |
| 14 | 43 | |
| 15 | 117 | |
| 16 | [Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results]. | 1 |
| 17 | 16 | |
| 18 | Partial bronchial stenosis following inadvertent right bronchial intubation in a neonate. | 6 |
| 19 | 49 | |
| 20 | Tc-99m-diethyl-IDA imaging: clinical evaluation in jaundiced patients. | 30 |
About G. Vandermoten
G. Vandermoten is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 21 papers that have together received 753 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (524 citations), Pulmonary and Respiratory Medicine (470 citations) and Epidemiology (162 citations). G. Vandermoten has collaborated with scholars based in Belgium and United States. Frequent co-authors include Jean‐Paul Sculier, P Libert, Jean Klášterský, P Ravez, G. Bureau, G Dabouis, J Thiriaux, J. Michel, Michel Richez and H. Lacroix. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.